Drug Trial Radar · NCT07209475
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
Last checked: Nov 20, 2026Latest source record: Oct 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
248
Planned (sponsor's estimate)
Start
Aug 14, 2025
Primary completion
Aug 14, 2026
Study completion Aug 14, 2026
Sponsor
- Lead sponsor
- Royal BiologicsIndustry
- Sponsor type
- Industry
- First posted
- Oct 7, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate a cellular, acellular, matrix-like product (CAMP) and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs). The study will evaluate Amnio-Maxx® Dual Layer Amnion Patch.
Conditions
- Diabetic Foot Ulcer (DFU)
- Amnio-Maxx
Interventions
Amnio-Maxx® Dual Layer Amnion PatchBiological
Application of Amnio-Maxx® Dual Layer Amnion Patch
Standard of Care (Investigator Choice)Other
Cleansing, debridement, wound documentation, off-loading
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Ulcer ClosureTime frame: 12 weeks
- Expected percentage area reduction (PAR)Time frame: 12-weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Lion Heart Clinical Research
Burbank, California · Recruiting
Royal Research South
Miami, Florida · Recruiting
Denali Health Atlanta, LLC
Stone Mountain, Georgia · Recruiting
SerenaGroup Research Center
Omaha, Nebraska · Recruiting
Suffolk Foot and Ankle
East Patchogue, New York · Recruiting
Wound Care of Tulsa
Tulsa, Oklahoma · Recruiting
VAST Clinical Research Carrollton Foot Center
Carrollton, Texas · Recruiting
Elite Foot & Ankle Associates
Spicewood, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.